Quality Control of 2,6-Dichlorobenzoic acid. About 2,6-Dichlorobenzoic acid, If you have any questions, you can contact Fogel, JM; Bonsall, D; Cummings, V; Bowden, R; Golubchik, T; de Cesare, M; Wilson, EA; Gamble, T; del Rio, C; Batey, DS; Mayer, KH; Farley, JE; Hughes, JP; Remien, RH; Beyrer, C; Fraser, C; Eshleman, SH or concate me.
Quality Control of 2,6-Dichlorobenzoic acid. Authors Fogel, JM; Bonsall, D; Cummings, V; Bowden, R; Golubchik, T; de Cesare, M; Wilson, EA; Gamble, T; del Rio, C; Batey, DS; Mayer, KH; Farley, JE; Hughes, JP; Remien, RH; Beyrer, C; Fraser, C; Eshleman, SH in OXFORD UNIV PRESS published article about in [Fogel, Jessica M.; Cummings, Vanessa; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Bonsall, David; Golubchik, Tanya; Fraser, Christophe] Univ Oxford, Big Data Inst, Nuffield Dept Med, Oxford, England; [Bowden, Rory; de Cesare, Mariateresa] Univ Oxford, Wellcome Ctr Human Genet, Oxford, England; [Wilson, Ethan A.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Gamble, Theresa] FHI 360, Durham, NC USA; [del Rio, Carlos] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [del Rio, Carlos] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [Batey, D. Scott] Univ Alabama Birmingham, Dept Social Work, Birmingham, AL USA; [Mayer, Kenneth H.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Mayer, Kenneth H.] Fenway Inst, Boston, MA USA; [Farley, Jason E.] Johns Hopkins Univ, REACH Initiat, Sch Nursing, Baltimore, MD USA; [Hughes, James P.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Remien, Robert H.] NY State Psychiat Inst, HIV Ctr Clin & Behav Studies, New York, NY USA; [Remien, Robert H.] Columbia Univ, Dept Psychiat, New York, NY USA; [Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA in 2020.0, Cited 17.0. The Name is 2,6-Dichlorobenzoic acid. Through research, I have a further understanding and discovery of 50-30-6
Objectives: To evaluate the performance of a high-throughput research assay for HIV drug resistance testing based on whole genome next-generation sequencing (NGS) that also quantifies HIV viral Load. Methods: Plasma samples (n = 145) were obtained from HIV-positive MSM (HPTN 078). Samples were analysed using clinical assays (the ViroSeq HIV-1 Genotyping System and the Abbott RealTime HIV-1 Viral Load assay) and a research assay based on whole-genome NGS (veSEQ-HIV). Results: HIV protease and reverse transcriptase sequences (n =142) and integrase sequences (n =138) were obtained using ViroSeq. Sequences from all three regions were obtained for 100 (70.4%) of the 142 samples using veSEQ-HIV; results were obtained more frequently for samples with higher viral Loads (93.5% for 93 samples with >5000 copies/mL; 50.0% for 26 samples with 1000-5000 copies/mL; 0% for 23 samples with <1000 copies/mL). For samples with results from both methods, drug resistance mutations (DRMs) were detected in 33 samples using ViroSeq and 42 samples using veSEQ-HIV (detection threshold: 5.0%). Overall, 146 major DRMs were detected; 107 were detected by both methods, 37 were detected by veSEQ-HIV only (frequency range: 5.0%-30.6%) and two were detected by ViroSeq only. HIV viral Loads estimated by veSEQ-HIV strongly correlated with results from the Abbott RealTime Viral Load assay (R-2 = 0.85; n = 142). Conclusions: The NGS-based veSEQ-HIV method provided results for most samples with higher viral Loads, was accurate for detecting major DRMs, and detected mutations at Lower Levels compared with a method based on population sequencing. The veSEQ-HIV method also provided HIV viral Load data.
Quality Control of 2,6-Dichlorobenzoic acid. About 2,6-Dichlorobenzoic acid, If you have any questions, you can contact Fogel, JM; Bonsall, D; Cummings, V; Bowden, R; Golubchik, T; de Cesare, M; Wilson, EA; Gamble, T; del Rio, C; Batey, DS; Mayer, KH; Farley, JE; Hughes, JP; Remien, RH; Beyrer, C; Fraser, C; Eshleman, SH or concate me.
Reference:
Chloride – Wikipedia,
,Chlorides – an overview | ScienceDirect Topics